Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2008
12/23/2008CA2410341C Chair
12/23/2008CA2334520C Treatment of immune diseases
12/23/2008CA2324115C A preventive or therapeutic agent for inflammatory bowel disease comprising il-6 antagonist as an active ingredient
12/23/2008CA2245267C Crystal form of n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
12/23/2008CA2182889C Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor
12/18/2008WO2008153159A1 Amine compound and pharmaceutical use thereof
12/18/2008WO2008153027A1 Pyrroloquinoline derivative and use thereof
12/18/2008WO2008152471A1 Quinazoline derivative useful as toll-like receptor antagonist
12/18/2008WO2008152423A2 Treatment of inflammation or autoimmune diseases with sulphated compounds
12/18/2008WO2008152421A2 Modification of cytokine levels with glucosylamine compounds
12/18/2008WO2008152149A1 Novel dicarboxylic acid derivatives as s1p1 receptor agonists
12/18/2008WO2008152067A1 An allergen dosage form comprising an antihistamine
12/18/2008WO2008151847A1 Autoantibody binding peptides and their use for the treatment of vascular diseases
12/18/2008WO2008151449A1 Method for the treatment of atopic eczema
12/18/2008WO2008151434A1 Small cationic antimicrobial peptides
12/18/2008WO2008151389A1 Chemically modified macromolecules
12/18/2008WO2008134513A3 Copper lowering treatment of autoimmune diseases
12/18/2008WO2008122892A3 Probiotics for use in reducing eosinophilia and respiratory allergies
12/18/2008WO2008115259A3 Derivatives of benzoxadiazole suitable for the treatment of cell proliferative diseases
12/18/2008WO2008094942A3 Humanized antibodies against cxcr3
12/18/2008WO2008093246A3 Vegf receptor antagonist for treating organ transplant alloimmunity and arteriosclerosis
12/18/2008WO2003024455A8 Stent coated with a sustained-release drug delivery and method for use thereof
12/18/2008US20080312438 -(2-Aminopyrid-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for immunoglobulins IgE and IgG antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis, multiple sclerosis
12/18/2008US20080312412 Chimeric protein including a protein from parainfluenza virus and a protein from respiratory syncytial virus, capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV); vaccines
12/18/2008US20080312334 4-hydroxy-2,3-dimethoxy-6-methyl-5(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone; to treat systemic lupus erythematosus; won't induce uncomfortable side effects, toxicity or complications
12/18/2008US20080312322 Organic Compounds
12/18/2008US20080312311 Crystalline forms of 3-(2R-tetrahydrofuryl-methyl)-2-thioxanthine
12/18/2008US20080312310 Compounds, Compositions and Methods
12/18/2008US20080312273 Quinoline Derivatives Having Vegf Inhibiting Activity
12/18/2008US20080312266 Steroidal Compounds For Inhibiting Steroid Sulphatase
12/18/2008US20080312259 SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
12/18/2008US20080312242 7-aryl-3, 9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
12/18/2008US20080312233 Therapeutic Morpholino-Substituted Compounds
12/18/2008US20080312229 Organic Compounds
12/18/2008US20080312227 Substituted Pyrido(2,3-D) Pyrimidine Derivatives Useful as Medicines for the Treatment of Autoimmune Disorders
12/18/2008US20080312217 N,N'-Bis-{4-[N'-(3,5-diamino-6-chloro-pyrazine-2-carbonyl)-guanidino]-butyl}terephthalamide, used for the treatment of conditions mediated by the blockade of an epithelial sodium channels
12/18/2008US20080312212 Organic Compounds
12/18/2008US20080312199 Treatments of therapy resistant diseases and drug combinations for treating the same
12/18/2008US20080312172 Anti-IL-6 Antibodies, Compositions, Methods and Uses
12/18/2008US20080312158 Semaphorin Gene Family
12/18/2008US20080311655 Heterodimeric fusion protein for use in the treatment of allergies and metastatic disease; cytokine linked to an antibody; nucleic acid encoding a fusion protein comprising an immunoglobulin (Ig) moiety linked by a peptide bond to the p35 subunit of interleukin-12
12/18/2008US20080311624 Chimeric immunogens
12/18/2008US20080311599 Antibodies against caspase-8, their preparation and use
12/18/2008US20080311229 Functional Food Composition For Treating Allergy, Natural Tea Using the Same and the Manufacturing Method Thereof
12/18/2008US20080311188 Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol
12/18/2008US20080311159 Methods and Means for Diagnostics, Prevention and Treatment of Mycobacterium Infections and Tuberculosis Disease
12/18/2008US20080311156 Vaccines
12/18/2008US20080311152 Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer
12/18/2008US20080311150 Novel sequences encoding hepatitis C virus glycoproteins
12/18/2008US20080311140 Antigen specific immunosuppression by dendritic cell therapy
12/18/2008US20080311138 Adjuvant Activity of Gastrointestinal Peptides
12/18/2008US20080311135 Immune complex vaccination as a strategy to enhance immunity in the elderly and other immune compromised populations
12/18/2008US20080311133 Methods of using multivalent mhc class ii-peptide chimeras
12/18/2008US20080311127 Combination therapy for treating disease
12/18/2008US20080311122 Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof
12/18/2008US20080311121 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability
12/18/2008US20080311117 Antibodies against PD-1 and uses therefor
12/18/2008US20080311098 Compounds and methods for modulating the immune response against antigens
12/18/2008US20080311095 Methods and compositions for increased transgene expression
12/18/2008US20080311083 Methods of Modulating Beta Cell Function
12/18/2008US20080311080 Bifidobacterium in the treatment of inflammatory disease
12/18/2008US20080311074 Inhibitors against activation of NF-kappaB
12/18/2008US20080311073 Ilt3 Polypeptides and Uses Thereof
12/18/2008US20080311034 Anti-Tissue Factor Antibodies and Compositions with Enhanced Effector Function
12/18/2008DE60224400T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure
12/18/2008DE102007043186A1 Cyclohexenonverbidungen aus Antrodia camphorata zur Behandlung von Autoimmunerkrankungen From Antrodia camphorata Cyclohexenonverbidungen for the treatment of autoimmune diseases
12/18/2008CA2693126A1 Novel dicarboxylic acid derivatives as s1p1 receptor agonists
12/18/2008CA2690686A1 Amine compound and pharmaceutical use thereof
12/18/2008CA2690267A1 Small cationic antimicrobial peptides
12/18/2008CA2687123A1 Method for the treatment of atopic eczema
12/17/2008EP2003203A1 Ligand for receptor activator of nf-kappa b, ligand is member of TNF superfamily
12/17/2008EP2003132A1 Hetero compound
12/17/2008EP2002842A2 Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator
12/17/2008EP2002832A2 Composition containing lignan compound
12/17/2008EP2001851A2 Amide derivatives and their application for the treament of g protein related diseases
12/17/2008EP2001842A2 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof
12/17/2008EP2001841A2 2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin d3 analogs and uses thereof
12/17/2008EP2001491A1 Anti-allergy compositions
12/17/2008EP1809607B1 Sulfonyl benzimidazole derivatives
12/17/2008EP1763342B1 Sphingolipids against pathological processes in lipid rafts
12/17/2008EP1614426B1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same
12/17/2008EP1536778B1 Proteins binding to cross-beta structure comprising amyloid and methods for modulation of the cross-beta structure, its formation and its associated toxicity
12/17/2008EP1425001B1 Phenethanolamine derivatives for treatment of respiratory diseases
12/17/2008EP1369119B1 Il-12 expression controlling agents
12/17/2008EP1230214B1 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
12/17/2008EP1077943B1 Heterocyclic inhibitors of p38
12/17/2008EP1024829B1 Tolerogenic fragments of natural allergens
12/17/2008CN101326280A Immunomodulation using placental stem cells
12/17/2008CN101326181A Imidazopyridine derivatives as a2b adenosine receptor antagonists
12/17/2008CN101326178A Piperazine derivatives useful as CCR5 antagonists
12/17/2008CN101326164A Inhibitors of CCR9 activity
12/17/2008CN101325960A Use of lactobacillus for treatment of virus infections
12/17/2008CN101325880A Oral tolerance promotion with glycated proteins
12/17/2008CN101323850A Lactobacillus helveticus microcapsule, preparation and use thereof
12/17/2008CN101323649A Method for extracting mushroom polysaccharide by using ultra-high pressure
12/17/2008CN101323643A Optimized TACI-Fc fuse protein
12/17/2008CN101322842A Recombinant Staphylococcus aureus enterotoxin G oral preparation and use
12/17/2008CN101322841A Recombinant Staphylococcus aureus enterotoxin J oral preparation and use
12/17/2008CN101322821A Health preserving wine and preparation
12/17/2008CN101322810A Chinese traditional medicine composition for treating diabetes respiratory tract infection
1 ... 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 ... 1172